Annual Cash & Cash Equivalents
$4.88 M
-$13.22 M-73.06%
31 December 2022
Summary:
Aridis Pharmaceuticals annual cash & cash equivalents is currently $4.88 million, with the most recent change of -$13.22 million (-73.06%) on 31 December 2022. During the last 3 years, it has fallen by -$13.22 million (-73.06%). ARDS annual cash & cash equivalents is now -80.57% below its all-time high of $25.10 million, reached on 31 December 2017.ARDS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$35.00 K
+$16.00 K+84.21%
30 September 2023
Summary:
Aridis Pharmaceuticals quarterly cash and cash equivalents is currently $35.00 thousand, with the most recent change of +$16.00 thousand (+84.21%) on 30 September 2023. ARDS quarterly cash and cash equivalents is now -99.90% below its all-time high of $34.08 million, reached on 30 September 2018.ARDS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARDS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -73.1% | -99.8% |
| 5 y5 years | -76.7% | -99.8% |
ARDS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -73.1% | at low | -99.8% | +84.2% |
| 5 y | 5 years | -76.7% | at low | -99.8% | +84.2% |
| alltime | all time | -80.6% | at low | -99.9% | +84.2% |
Aridis Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $35.00 K(+84.2%) |
| June 2023 | - | $19.00 K(-98.6%) |
| Mar 2023 | - | $1.32 M(-72.9%) |
| Dec 2022 | $4.88 M(-73.1%) | $4.88 M(+158.5%) |
| Sept 2022 | - | $1.89 M(-70.1%) |
| June 2022 | - | $6.32 M(-49.4%) |
| Mar 2022 | - | $12.47 M(-31.1%) |
| Dec 2021 | $18.10 M(+119.8%) | $18.10 M(-0.7%) |
| Sept 2021 | - | $18.22 M(+407.3%) |
| June 2021 | - | $3.59 M(-65.7%) |
| Mar 2021 | - | $10.47 M(+27.2%) |
| Dec 2020 | $8.23 M | $8.23 M(+32.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $6.21 M(-47.4%) |
| June 2020 | - | $11.81 M(-27.6%) |
| Mar 2020 | - | $16.32 M(-21.9%) |
| Dec 2019 | $20.90 M(-13.8%) | $20.90 M(+20.6%) |
| Sept 2019 | - | $17.33 M(+103.4%) |
| June 2019 | - | $8.52 M(-47.8%) |
| Mar 2019 | - | $16.31 M(-32.7%) |
| Dec 2018 | $24.24 M(-3.4%) | $24.24 M(-28.9%) |
| Sept 2018 | - | $34.08 M(+153.0%) |
| June 2018 | - | $13.47 M(-33.9%) |
| Mar 2018 | - | $20.39 M(-18.8%) |
| Dec 2017 | $25.10 M(+12.6%) | $25.10 M |
| Dec 2016 | $22.29 M | - |
FAQ
- What is Aridis Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Aridis Pharmaceuticals?
What is Aridis Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of ARDS is $4.88 M
What is the all time high annual cash & cash equivalents for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high annual cash & cash equivalents is $25.10 M
What is Aridis Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ARDS is $35.00 K
What is the all time high quarterly cash and cash equivalents for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high quarterly cash and cash equivalents is $34.08 M